Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr:93:107397.
doi: 10.1016/j.intimp.2021.107397. Epub 2021 Jan 22.

COVID-19 associated thrombotic thrombocytopenic purpura (TTP) ; A case series and mini-review

Affiliations
Review

COVID-19 associated thrombotic thrombocytopenic purpura (TTP) ; A case series and mini-review

Hamed Azhdari Tehrani et al. Int Immunopharmacol. 2021 Apr.

Abstract

Introduction: Thrombotic microangiopathies are a group of disorders that are mainly related to endothelial dysfunction. This category of endothelial dysfunction results of several imbalances between platelets, endothelium and immune system, also cytokine production.

Aim of this study: To report cases with thrombotic thrombocytopenic purpura (TTP) and COVID-19 and review COVID-19 endothelial dysfunction literature.

Methods: Primary laboratory data, peripheral blood smear, ADAMTS13 antigen activity level, and antibody ordered for each of these four patients. Treatments for COVID-19 administered for all patients. Traditional treatments for TTP also were administered.

Results: There were numerous schistocytes (more than 5%) in peripheral blood smears for each patient. ADAMTS13 antigen activity level was below 10%, and ADAMTS13 antibody was elevated for each patient. COVID-19 PCR was positive for all patients, and CT-Scans were indicative of the involvement of COVID-19.

Conclusion: In this case series, we reported four COVID-19 patients who presented with signs and symptoms of anemia and thrombocytopenia, resulting in thrombotic thrombocytopenic purpura.

Keywords: COVID-19; Case Series; TTP; Thrombotic microangiopathy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

References

    1. Zipfel P.F., Heinen S., Skerka C. Thrombotic microangiopathies: new insights and new challenges. Curr. Opin. Nephrol. Hypertens. 2010 Jul;19(4):372–378. - PubMed
    1. Htet Z., Karim M. Thrombotic microangiopathy with renal injury: an approach for the general physician. J. R. Coll. Physicians Edinb. 2020 Mar;50(1):25–31. - PubMed
    1. Moake J.L. Thrombotic microangiopathies. N. Engl. J. Med. 2002 Aug 22;347(8):589–600. - PubMed
    1. George J.N., Nester C.M., McIntosh J.J. Syndromes of thrombotic microangiopathy associated with pregnancy. Hematol. Am. Soc. Hematol. Educ. Program. 2015;2015:644–648. - PubMed
    1. Helms J., Tacquard C., Severac F., Leonard-Lorant I., Ohana M., Delabranche X., Merdji H., Clere-Jehl R., Schenck M., Fagot Gandet F., Fafi-Kremer S., Castelain V., Schneider F., Grunebaum L., Anglés-Cano E., Sattler L., Mertes P.M., Meziani F. CRICS TRIGGERSEP Group (Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis). High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020 Jun;46(6):1089–1098. - PMC - PubMed